(Q39202758)

9 September 2017

title

Biomarkers in hepatocellular carcinoma: an overview (English)

1 reference

Norberto Carlos Chávez-Tapia

9 September 2017

0 references

hepatocellular carcinoma

1 reference

4

Misael Uribe

0 references

3

object named as

Norberto Carlos Chávez-Tapia

0 references

author name string

Eva Juárez-Hernández

1

1 reference

9 September 2017

Daniel Motola-Kuba

2

1 reference

9 September 2017

Varenka Barbero Becerra

5

1 reference

9 September 2017

publication date

27 March 2017

1 reference

Expert Review of Gastroenterology & Hepatology

9 September 2017

published in

1 reference

9 September 2017

volume

11

1 reference

9 September 2017

issue

6

1 reference

9 September 2017

page(s)

549-558

1 reference

Somatostatin receptor expression in hepatocellular carcinoma: prognostic and therapeutic considerations.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Tivantinib: critical review with a focus on hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Targeting the c-Met signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

An operational definition of epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Cellular reprogramming for understanding and treating human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

AMP-activated protein kinase regulates beta-catenin transcription via histone deacetylase 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Circulating RNA molecules as biomarkers in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Clinical relevance of circulating cell-free microRNAs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

DNA methylation: potential biomarker in Hepatocellular Carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Imaging techniques for the diagnosis of hepatocellular carcinoma and the evaluation of response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Des-gamma-carboxy prothrombin (DCP) antagonizes the effects of gefitinib on human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Association of Paraoxonase 1 Gene Polymorphisms With the Risk of Hepatitis B Virus-related Liver Diseases in a Guangxi Population: A Case-control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Signaling pathways activation profiles make better markers of cancer than expression of individual genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

CXCR7: a novel tumor endothelial marker in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Serologic and molecular biomarkers for recurrence of hepatocellular carcinoma after liver transplantation: A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Biomarker Analyses of Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib with or without Erlotinib in the SEARCH Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

MicroRNAs in B-cell lymphomas: how a complex biology gets more complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Fluorescent Nanocomposite for Visualizing Cross-Talk between MicroRNA-21 and Hydrogen Peroxide in Ischemia-Reperfusion Injury in Live Cells and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

DNA Methylation and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1311785

10.1080/17474124.2017.1311785

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference